The RNA-binding protein SDOS regulates pro-survival autophagy in response to DNA damage in breast cancer cells

Breast cancer remains the most frequently diagnosed cancer in women worldwide and the second leading cause of cancer-related death among them. To understand how this disease persists and resists treatment, scientists often look at two critical cellular processes: how cells repair their genetic code when it is broken, and how they recycle their own damaged parts to stay alive. When a cell's DNA is damaged, often by the very drugs used to treat cancer, it must decide whether to repair itself or die. One key player in the repair process is a protein called 53BP1, which acts as a manager directing the cell to fix broken DNA strands. However, another protein, known as SDOS, can interfere with this manager, sometimes making cancer cells resistant to treatment. Separately, cells have a survival mechanism called autophagy, a self-cleaning process where the cell digests its own worn-out components to generate energy and clear debris. This process is controlled by a specific receptor protein named SQSTM1, which acts like a tagger, marking damaged parts for disposal. The question researchers have long faced is whether these two distinct survival strategies—DNA repair and self-cleaning—are linked by a single master regulator, and if so, how that connection helps cancer cells survive the stress of chemotherapy.

A team of researchers at the University of Naples Federico II has uncovered a surprising link between these systems, revealing that the protein SDOS acts as a dual-purpose regulator that helps breast cancer cells survive DNA damage by controlling both the repair machinery and the self-cleaning process. The scientists focused on SDOS, a protein that is known to sit in the nucleus and block the DNA repair manager, but they also discovered it lives in the cell's main body, or cytoplasm, where it interacts with the machinery that builds new proteins. By studying breast cancer cells in the lab, the team found that SDOS does not just sit idle; it actively manages the production and activity of the SQSTM1 protein. Under normal conditions, SDOS keeps the production of SQSTM1 in check. However, when the cells are exposed to DNA-damaging agents like etoposide, a common chemotherapy drug, SDOS changes its behavior. It releases its hold on the instructions for making SQSTM1, allowing the cell to rapidly produce more of this self-cleaning tagger. At the same time, SDOS helps activate the existing SQSTM1 protein by removing a small molecular inhibitor that usually keeps it dormant. This double action ensures that when the cell is under attack, it can immediately ramp up its autophagy system to recycle damaged parts and survive the stress.

The researchers confirmed this mechanism through a series of careful experiments using human breast cancer cells. They first observed that SDOS physically binds to the SQSTM1 protein. While previous studies suggested SDOS might bind the genetic instructions for SQSTM1, the team's specific tests (RIP assays) did not show a direct enrichment of the SQSTM1 transcript in the SDOS complex, indicating that SDOS regulates the protein's activity rather than directly binding its RNA instructions in this context. When they silenced the SDOS gene, the cells produced too much SQSTM1 protein even without stress, but when they added DNA-damaging drugs, these cells failed to sustain the production of new SQSTM1. In contrast, cells with normal levels of SDOS were able to increase their production of SQSTM1 specifically when the DNA was damaged. The team also watched how the proteins interacted in real-time. They saw that when DNA damage occurred, SDOS let go of the SQSTM1 protein, allowing it to become active and start the cleaning process. Simultaneously, SDOS grabbed onto a small molecule called vault RNA, which normally acts as a brake on SQSTM1. The study showed that SDOS binds to this vault RNA specifically upon DNA damage, suggesting that this interaction contributes to SQSTM1 activation by sequestering the vault RNA. This coordinated release and activation allowed the cancer cells to maintain a high level of autophagy, which protected them from dying.

To test if this survival mechanism actually mattered, the researchers treated the cells with DNA-damaging drugs and then blocked the autophagy process. When autophagy was stopped, the cells that relied on SDOS to survive were much more likely to die than those that did not. This proved that the ability to boost autophagy through SDOS was a key reason why some cancer cells could withstand chemotherapy. The study also looked at real human tissue samples to see if this relationship existed outside the lab. They found that in normal breast tissue, the genes for SDOS and SQSTM1 did not show a strong connection. However, in breast cancer tumors, and even more so in metastatic tumors that had spread to other parts of the body, the levels of both proteins rose together. This suggests that as the cancer becomes more aggressive, it increasingly relies on this SDOS-driven survival loop to protect itself from treatment.

The findings suggest that SDOS is a crucial switch that cancer cells flip to survive the stress of DNA damage. It works by holding back the production of the self-cleaning protein until the moment it is needed, and then helping to activate it instantly. This discovery adds a new layer of understanding to how cancer cells resist treatment, showing that they do not just rely on one method of survival but coordinate multiple systems through a single protein. While the study does not yet offer a new drug, it highlights a specific vulnerability: if scientists can find a way to stop SDOS from helping the cell activate its self-cleaning system, they might be able to make chemotherapy more effective against breast cancer. The research provides a clear picture of how a single protein can manage both the repair of genetic damage and the recycling of cellular waste, ensuring the cancer cell remains alive even when under heavy attack.